Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
D

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

Watchlist Manager
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Watchlist
Price: 304 IDR Market Closed
Market Cap: Rp380B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
3Y
+44%
5Y
+85%
10Y
-
Operating Income
+
3Y
-
5Y
-
10Y
-
Net Income
+
3Y
-
5Y
-
10Y
-

Earnings Waterfall
Diagnos Laboratorium Utama PT Tbk

Income Statement
Diagnos Laboratorium Utama PT Tbk

Rotate your device to view
Income Statement
Currency: IDR
Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
882
0
0
0
Revenue
95 668
N/A
152 031
+59%
183 171
+20%
255 411
+39%
307 629
+20%
333 309
+8%
302 182
-9%
272 200
-10%
230 248
-15%
195 178
-15%
192 886
-1%
172 634
-10%
167 242
-3%
156 173
-7%
145 696
-7%
149 805
+3%
155 530
+4%
163 072
+5%
239 569
+47%
239 955
+0%
281 346
+17%
Gross Profit
Cost of Revenue
(56 531)
(82 763)
(96 461)
(130 553)
(148 471)
(164 062)
(151 681)
(136 331)
(122 904)
(105 470)
(97 881)
(92 405)
(92 112)
(89 315)
(85 899)
(86 768)
(88 233)
(90 238)
(134 295)
(133 781)
(155 212)
Gross Profit
39 137
N/A
69 268
+77%
86 710
+25%
124 859
+44%
159 158
+27%
169 247
+6%
150 500
-11%
135 868
-10%
107 344
-21%
89 708
-16%
95 006
+6%
80 229
-16%
75 129
-6%
66 857
-11%
59 797
-11%
63 037
+5%
67 297
+7%
72 834
+8%
105 274
+45%
106 175
+1%
126 135
+19%
Operating Income
Operating Expenses
(15 664)
(20 575)
(19 735)
(32 052)
(43 569)
(52 799)
(67 221)
(69 623)
(70 471)
(76 165)
(77 672)
(77 296)
(78 634)
(76 125)
(73 370)
(72 956)
(73 022)
(70 910)
(106 107)
(107 088)
(126 206)
Selling, General & Administrative
(11 880)
(17 696)
(18 323)
(29 730)
(43 596)
(51 016)
(66 143)
(66 737)
(65 528)
(70 103)
(72 298)
(72 075)
(73 151)
(70 974)
(65 503)
(64 152)
(64 701)
(61 766)
(91 817)
(92 880)
(110 434)
Research & Development
(1 106)
0
(593)
(683)
0
0
(274)
(390)
(543)
(714)
(586)
0
(510)
(364)
(249)
(484)
(337)
(759)
(1 171)
(1 200)
(1 415)
Depreciation & Amortization
(877)
(1 009)
(808)
(1 125)
(1 177)
(2 199)
(2 857)
(4 002)
(5 249)
(6 032)
(6 683)
(7 237)
(7 500)
(7 633)
(8 154)
(8 161)
(8 337)
(8 349)
(12 524)
(12 485)
(14 145)
Other Operating Expenses
(1 801)
(1 870)
(11)
(515)
1 204
416
2 052
1 506
848
685
1 895
2 015
2 528
2 847
535
(159)
352
(36)
(596)
(522)
(212)
Operating Income
23 473
N/A
48 692
+107%
66 975
+38%
92 807
+39%
115 590
+25%
116 448
+1%
83 279
-28%
66 245
-20%
36 873
-44%
13 543
-63%
17 333
+28%
2 933
-83%
(3 504)
N/A
(9 267)
-164%
(13 573)
-46%
(9 919)
+27%
(5 725)
+42%
1 924
N/A
(833)
N/A
(914)
-10%
(72)
+92%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(774)
(176)
(350)
(527)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(286)
(21)
(1)
(1)
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
23 473
N/A
48 692
+107%
66 975
+38%
92 807
+39%
115 590
+25%
116 448
+1%
83 279
-28%
66 245
-20%
36 873
-44%
13 543
-63%
17 333
+28%
2 933
-83%
(3 504)
N/A
(9 267)
-164%
(13 573)
-46%
(9 919)
+27%
(5 725)
+42%
864
N/A
(1 030)
N/A
(1 265)
-23%
(600)
+53%
Net Income
Tax Provision
(5 998)
(11 669)
(14 289)
(19 889)
(25 012)
(27 535)
(18 975)
(15 336)
(8 233)
(1 055)
(4 669)
(2 134)
(1 997)
(878)
(83)
(53)
965
(116)
993
0
(1 303)
Income from Continuing Operations
17 475
37 023
52 687
72 918
90 578
88 913
64 304
50 909
28 639
12 488
12 665
799
(5 502)
(10 146)
(13 656)
(9 973)
(4 759)
747
(38)
(1 381)
(1 903)
Net Income (Common)
17 475
N/A
37 023
+112%
52 687
+42%
72 918
+38%
90 578
+24%
88 913
-2%
64 304
-28%
50 909
-21%
28 639
-44%
12 488
-56%
12 665
+1%
799
-94%
(5 502)
N/A
(10 146)
-84%
(13 656)
-35%
(9 973)
+27%
(4 759)
+52%
747
N/A
(38)
N/A
(1 381)
-3 552%
(1 903)
-38%
EPS (Diluted)
13.98
N/A
74.04
+430%
42.15
-43%
58.33
+38%
72.46
+24%
71.13
-2%
51.44
-28%
40.73
-21%
22.91
-44%
9.99
-56%
10.13
+1%
0.64
-94%
-4.4
N/A
-8.12
-85%
-10.92
-34%
-7.98
+27%
-3.81
+52%
0.6
N/A
-0.03
N/A
-1.11
-3 600%
-1.52
-37%

See Also

Summary
DGNS intrinsic value, competitors valuation, and company profile.
DCF Valuation
DGNS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DGNS stock valuation using valuation multiples.
Wall Street Estimates
DGNS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DGNS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.